These results, along with a earlier report showing that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 support the concept of focusing on ACKR3 as a unique technique to modulate the opioid process, which could open new therapeutic avenues for opioid-connected Conditions. Helps to reduce Serious suffering https://howardy993mrr3.liberty-blog.com/profile